A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan
City of Hope Medical Center
City of Hope Medical Center
University of Nebraska
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
Barbara Ann Karmanos Cancer Institute
Bambino Gesù Hospital and Research Institute
M.D. Anderson Cancer Center